Albany Molecular Research Inc

CIK 1065087 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Albany Molecular Research Inc.

Recent SEC filings

FiledFormAccession number
Feb 14, 2018SC 13G/A0000905718-18-000203
Feb 13, 2018SC 13G/A0000945621-18-000079
Sep 22, 2017EFFECT9999999995-17-002437
Sep 22, 2017EFFECT9999999995-17-002432
Sep 22, 2017EFFECT9999999995-17-002444
Sep 22, 2017EFFECT9999999995-17-002433
Sep 22, 2017EFFECT9999999995-17-002445
Sep 22, 2017EFFECT9999999995-17-002436
Sep 22, 2017EFFECT9999999995-17-002434
Sep 5, 201740001638599-17-000873
Sep 5, 2017SC 13D/A0001144204-17-046624
Sep 5, 201740001638599-17-000882
Sep 5, 201740001638599-17-000870
Sep 5, 201740001638599-17-000876
Sep 5, 201740001638599-17-000881
Sep 5, 2017SC 13D/A0001144204-17-046620
Sep 5, 2017SC 13D/A0001144204-17-046632
Sep 5, 201740001638599-17-000869
Sep 5, 2017SC 13D/A0001144204-17-046622
Sep 5, 201740001638599-17-000868
Sep 5, 201740001638599-17-000872
Sep 5, 201740001638599-17-000871
Sep 5, 201740001638599-17-000866
Sep 5, 201740001638599-17-000874
Sep 5, 201740001638599-17-000867